RecruitingPhase 2NCT06905132

Preoperative 5-Day Radiotherapy for Soft Tissue Sarcoma

Preoperative 5-Day Radiotherapy for Soft Tissue Sarcoma: A Single Institution Phase II Trial


Sponsor

Medical University of South Carolina

Enrollment

40 participants

Start Date

Apr 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this research study is to preserve healthy tissue around the cancer on the arm(s) and/or leg(s) using Hypofractionated radiotherapy, while treating the cancer and preventing it from spreading to other areas of the body.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a shorter, 5-day course of radiation therapy before surgery works as well as the standard 5-week course for people with soft tissue sarcoma (a cancer of muscles, fat, or connective tissues) — making treatment more convenient without sacrificing effectiveness. **You may be eligible if...** - You are 18 or older - You have been diagnosed with soft tissue sarcoma of the arm, leg, or trunk confirmed by biopsy - You are considered eligible for surgery to remove the tumor (wide local excision) - You or your doctor have identified barriers to completing a 5-week daily radiation schedule (such as travel burden, financial concerns, or risk of tumor progression during a long treatment) - Your overall health is acceptable (ECOG performance status 0–3) **You may NOT be eligible if...** - You are not a candidate for surgery - You have already completed radiation therapy for this tumor - You have certain medical conditions that make radiation unsafe Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONHypofractionated Radiation Therapy

Participants will receive preoperative 5-day HFRT (30Gy/5fx once daily over consecutive weekdays) followed by "standard of care" wide local excision 2-6 weeks later.


Locations(1)

Medical University of South Carolina

Charleston, South Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06905132


Related Trials